Cost-Effectiveness of HPV Self-Testing Options for Cervical Cancer Screening.

ABSTRACT:

Importance

Mailing human papillomavirus (HPV) self-sampling kits to underscreened individuals increases cervical cancer screening and can be cost-effective. However, cost-effectiveness has not been evaluated across other screening histories.

Objective

To conduct an economic evaluation of mailed HPV self-sampling among members of a US health care system with adherent, overdue, or unknown screening histories.

Design, setting, and participants

This economic evaluation was a cost-effectiveness analysis (CEA) and budget impact analysis (BIA) based on results of a randomized clinical trial (RCT) conducted between November 20, 2020, to July 29, 2022, in an integrated health care system in Washington State. Intervention delivery costs were calculated from Kaiser Permanente Wa

SUBMITTER: Meenan RT 

PROVIDER: S-EPMC12489673 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature